← All trials
NCT04649645
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 28, 2021
- Primary completion
- Feb 28, 2023
- Completion date
- Apr 28, 2023
- First posted
- Dec 2, 2020
- Last posted
- Feb 21, 2021
- Enrollment
- 606
- Arms / groups
- 3 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Eclat Srl.Lead sponsor
- University of CataniaCollaborator
- Addendo srl, Catania, ItalyOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.